Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer
Eileen Rillamas‐Sun, Marilyn L. Kwan, Carlos Iribarren, Richard K. Cheng, Romain Neugebauer, Jamal S. Rana, Mai N. Nguyen‐Huynh, Zaixing Shi, Cecile A. Laurent, Valerie S. Lee, Janise M. Roh, Yuhan Huang, Hanjie Shen, Dawn L. Hershman, Lawrence H. Kushi, Heather Greenlee
Topics & Concepts
MedicineTamoxifenDyslipidemiaHazard ratioBreast cancerInternal medicineDiabetes mellitusProportional hazards modelOncologyHormone therapyGynecologyCancerEndocrinologyConfidence intervalDiseaseCancer Risks and FactorsMetabolism, Diabetes, and CancerEstrogen and related hormone effects